Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Bibliographic Details
Main Authors:	Gurka, Marie K, Chen, Leonard N, Bhagat, Aditi, Moures, Rudy, Kim, Joy S, Yung, Thomas, Lei, Siyuan, Collins, Brian T, Krishnan, Pranay, Suy, Simeng, Dritschilo, Anatoly, Lynch, John H, Collins, Sean P
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358866/

Similar Items

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
by: Chen, Leonard N, et al.
Published: (2014)

Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm3)
by: Janowski, Einsley, et al.
Published: (2014)

Proctitis following stereotactic body radiation therapy for prostate cancer
by: Joh, Daniel Y, et al.
Published: (2014)

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
by: Arscott, W Tristram, et al.
Published: (2014)

Clinical Characteristics and Management of Late Urinary Symptom Flare Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Woo, Jennifer A., et al.
Published: (2014)

The Prostate Clinical Outlook (PCO) Classifier Application for Predicting Biochemical Recurrences in Patients Treated by Stereotactic Body Radiation Therapy (SBRT)
by: Seong K. Mun, et al.
Published: (2018-09-01)

Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer
by: Bhattasali, Onita, et al.
Published: (2013)

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
by: Chen, Leonard N, et al.
Published: (2013)

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
by: Bhattasali, Onita, et al.
Published: (2014)

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?
by: Woo, Jennifer Ai-Lian, et al.
Published: (2015)

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Janowski, Einsley-Marie, et al.
Published: (2015)

Improved Irritative Voiding Symptoms 3 Years after Stereotactic Body Radiation Therapy for Prostate Cancer
by: Rana, Zaker, et al.
Published: (2014)

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design
by: Paydar, Ima, et al.
Published: (2016)

Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging
by: Paydar, Ima, et al.
Published: (2015)

Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
by: Repka, Michael C., et al.
Published: (2016)

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
by: Sood, Sumit, et al.
Published: (2013)

Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience
by: Mercado, Catherine, et al.
Published: (2016)

Potency preservation following stereotactic body radiation therapy for prostate cancer
by: Obayomi-Davies, Olusola, et al.
Published: (2013)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
by: Gurka, Marie K., et al.
Published: (2017)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
by: Ju, Andrew W, et al.
Published: (2013)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
by: Lischalk, Jonathan W., et al.
Published: (2016)

Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
by: Oermann, Eric K, et al.
Published: (2011)

Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy
by: Lei, Siyuan, et al.
Published: (2011)

Stereotactic Body Radiation Therapy for Liver Metastases from Colorectal Cancer: Analysis of Safety, Feasibility, and Early Outcomes
by: Kress, Marie-Adele S., et al.
Published: (2012)

Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors
by: Kress, Marie-Adele S, et al.
Published: (2012)

Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
by: Gill, Beant, et al.
Published: (2012)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
by: Mahadevan, Anand, et al.
Published: (2015)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
by: Stauder, Michael C., et al.
Published: (2010)

The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer
by: Koneru, Harsha, et al.
Published: (2016)

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety
by: Gurka, Marie K, et al.
Published: (2013)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
by: Dash, Chiranjeev, et al.
Published: (2012)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney, Brandon M, et al.
Published: (2012)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
by: Navarria, Pierina, et al.
Published: (2014)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
by: Gregor Habl, et al.
Published: (2017-05-01)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
by: Rosanna Yeung, et al.
Published: (2017-06-01)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
by: Vargo, John A., et al.
Published: (2015)

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
by: Dagoglu, Nergiz, et al.
Published: (2016)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
by: Lischalk, Jonathan W., et al.
Published: (2016)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
by: Yasutaka Ogawa, et al.
Published: (2018-07-01)

Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk
by: Michael C. Repka, et al.
Published: (2018-09-01)